Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Select your species
Human ESM1 Kit ELISA pour Sandwich ELISA - ABIN418159
Li, Wang, Wang, Wang, Yang, Liang, Jin: Detection on dynamic changes of endothelial cell specific molecule-1 in acute rejection after renal transplantation. dans Urology 2012
Show all 4 Pubmed References
Human ESM1 Kit ELISA pour Sandwich ELISA - ABIN856973
Nirala, Perumal, Gohil: Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction. dans Diabetes & vascular disease research 2015
Show all 3 Pubmed References
glomerular-derived Esm-1 as a potential non-invasive biomarker of diabetic nephropathy
Results reveal a novel pathway for endocan in the control of tumor growth, which involves inflammatory cells of the innate immunity.
Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability.
This study shows endocan can elicit severe inflammatory responses and inhibiting endocan release offers a potential strategy for treating sepsis.
endocan is normally present in the mouse brain and prior vascular perfusion with FITC may provide a useful tool for identify newly forming blood vessels.
Mouse endocan serum level was measured at a median of 0.96 ng/mL and 1.08 ng/mL in 129Sv mice and C57bl6, respectively.
A paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 (Montrer EDN1 Kits ELISA) acting on the vascular smooth muscle ET(A (Montrer EDNRA Kits ELISA)) receptor.
Results suggest that endocan (ESM-1)is preferentially expressed in tumor endothelium in vivo and that its expression is regulated by tumor-derived factors.
Endocan expression was correlated with poor clinical outcomes in patients with Pancreatic Neuroendocrine Tumors . The results indicated that endocan expression may be a reliable marker for predicting tumor recurrence in patients with PNETs.
Physical activity increases circulating endocan level.
These findings provide the first evidence that the imbalance of MMP-9 (Montrer MMP9 Kits ELISA)/TIMP-1 (Montrer TIMP1 Kits ELISA), is one of the regulation mechanisms by which ESM1 promotes tumorigenicity and metastasis of prostate cancer cells.
These results are consistent with the view that endocan measured in ICU patients is intact, stable, and accurate. Then, the low endocan level observed in ICU patients who developed acute respiratory distress syndrome is likely to be reliable.
Dopamine agonist resistance-related ESM1 promotes the angiogenesis and tumor cells growth of prolactinomas, suggesting that ESM1 may be a novel therapeutic target for prolactinomas.
These results suggest human cytomegalovirus infection leads to glioma progression through an upregulation of endocan and the secretion of inflammatory cytokines.
Endocan-expressing microvessel density significantly correlates with the expression of VEGF (Montrer VEGFA Kits ELISA) and VEGFR2 (Montrer KDR Kits ELISA) and is a valuable prognostic factor for survival in human gastric cancer.
Circulating P-selectin (Montrer SELP Kits ELISA) levels were closely associated with endocan levels in obese children and adolescents with non-alcoholic fatty liver disease.
this study shows that endocan may play an important role in the development of connective tissue disease related pulmonary arterial hypertension
This gene encodes a secreted protein which is mainly expressed in the endothelial cells in human lung and kidney tissues. The expression of this gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. The transcript contains multiple polyadenylation and mRNA instability signals. Two transcript variants encoding different isoforms have been found for this gene.
endothelial cell-specific molecule 1
, ESM-1 secretory protein
, pineal specific PG25 protein